Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

NCT07749924 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

670

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Non-Muscle-Invasive Bladder Cancer (NMIBC)

Interventions

OTHER: Active Surveillance
DRUG: Adjuvant Intravesical Chemotherapy

Sponsor

Tianjin Medical University Second Hospital